Sign In
Buy MLTX
$19.02
-0.340 (-1.76%)
At Close: Jul 24, 2026
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at MoonLake Immunotherapeutics
11:39am, Thursday, 06'th Nov 2025
NEW YORK--(BUSINESS WIRE)---- $MLTX #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Reuters Research Inc. (“MoonLake” or the �
Portnoy Law Firm Announces Class Action on Behalf of Moonlake Immunotherapeutics, Inc. Investors
11:18am, Thursday, 06'th Nov 2025
LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises MoonLake Immunotherapeutics, Inc., (“MoonLake” or the "Company") (NASDAQ: MLTX) investors off a class action on behalf o
Levi & Korsinsky Notifies MoonLake Immunotherapeutics (MLTX) Investors - Lead Plaintiff Deadline on December 15, 2025
09:19am, Thursday, 06'th Nov 2025
New York, New York--(Newsfile Corp. - November 6, 2025) - If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or a
The Gross Law Firm Notifies Shareholders of MoonLake Immunotherapeutics(MLTX) of a Class Action Lawsuit and an Upcoming Deadline
08:45am, Thursday, 06'th Nov 2025
NEW YORK , Nov. 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX). Shareholders who purchased shares of MLTX during t
New York, New York--(Newsfile Corp. - November 5, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) betw
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering
07:11am, Wednesday, 05'th Nov 2025
ZUG, Switzerland, November 5, 2025 – MoonLake Immunotherapeutics (Nasdaq: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on advancing therapies to address significant unmet n
ZUG, Switzerland, November 5, 2025 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake” or the “Company”), a clinical-stage biotechnology company focused on creating next-level therapies
SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the MoonLake class action lawsuit – captioned Peters v. MoonLake Immunotherapeutics, No.
Class Action Alert: Levi & Korsinsky Reminds MoonLake (MLTX) Investors of December 15, 2025 Deadline
03:38pm, Tuesday, 04'th Nov 2025
New York, New York--(Newsfile Corp. - November 4, 2025) - If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
03:26pm, Tuesday, 04'th Nov 2025
BENSALEM, Pa. , Nov. 4, 2025 /PRNewswire/ -- The Law Offices of Howard G.
New York, New York--(Newsfile Corp. - November 4, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds
NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2
New York, New York--(Newsfile Corp. - November 4, 2025) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized law firm,
